TrialDiabetologia2026

Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study.

What the trial testedrandomised · 14 people · 2026

Randomised comparison

−36.0percentage points−57.0 to −14.0

As reported

difference −36.0 %, 95% CI −57.0 to −14.0

the abstract, start to end

… that the iAUC for glucose decreased by 36% (95% CI 14, 57) with KE and …

← favours treatmentfavours comparator →

could be chance

Glycemic control

−36.0−57.0 to −14.0

MetforminGlycemic control

Metformin × glycemic controlhelps?replicated

unlikelylikely

0.840.84 without it

← favours treatmentfavours comparator →

this papermore certainless certain

1 / 5